Jacobs Levy Equity Management, Inc Intercept Pharmaceuticals, Inc. Transaction History

Jacobs Levy Equity Management, Inc

$21.8 Billion
Q1 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$9.17 - $19.29 $564,578 - $1.19 Million	-61,568 Reduced 6.67%	861,801 $9.53 Million
Q1 2023 May 15, 2023	BUY	$12.53 - $21.71 $3,282 - $5,688	262 Added 0.03%	923,369 $12.4 Million
Q4 2022 Feb 14, 2023	BUY	$11.61 - $16.11 $1.65 Million - $2.29 Million	142,162 Added 18.2%	923,107 $11.4 Million
Q3 2022 Nov 15, 2022	BUY	$12.21 - $19.7 $1.65 Million - $2.66 Million	135,254 Added 20.95%	780,945 $10.9 Million
Q2 2022 Aug 15, 2022	BUY	$11.23 - $19.59 $599,536 - $1.05 Million	53,387 Added 9.01%	645,691 $8.92 Million

Q1 2022 May 16, 2022	BUY	$13.37 - $17.79 $45,217 - $60,165	3,382 Added 0.57%	592,304 $9.64 Million
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $781,772 - $1.07 Million	54,746 Added 10.25%	588,922 $9.59 Million
Q3 2021 Nov 15, 2021	SELL	$12.99 - $20.47 $1.04 Million - $1.63 Million	-79,712 Reduced 12.98%	534,176 $7.93 Million
Q2 2021 Aug 16, 2021	BUY	$15.46 - $24.5 $1.26 Million - $2 Million	81,786 Added 15.37%	613,888 $12.3 Million
Q1 2021 May 17, 2021	BUY	$19.33 - $37.75 $1.01 Million - $1.98 Million	52,378 Added 10.92%	532,102 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $3.24 Million - $5.63 Million	132,478 Added 38.15%	479,724 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$39.09 - $53.44 $11.6 Million - $15.9 Million	297,789 Added 602.12%	347,246 $14.4 Million
Q2 2020 Aug 17, 2020	BUY	$46.7 - $92.04 $254,748 - $502,078	5,455 Added 12.4%	49,457 $2.37 Million
Q1 2020 May 15, 2020	SELL	$48.35 - $118.68 $16,439 - $40,351	-340 Reduced 0.77%	44,002 $2.77 Million
Q4 2019 Feb 14, 2020	BUY	$57.36 - $124.1 $232,308 - $502,605	4,050 Added 10.05%	44,342 $5.5 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $2.36 Million - $3.24 Million	40,292 New	40,292 $2.67 Million

Others Institutions Holding ICPT

# of Institutions

Shares Held

1.04M

Call Options Held

30K

Put Options Held

5.9K

View Full List

About INTERCEPT PHARMACEUTICALS, INC.

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

More about ICPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Account